14-day Premium Trial Subscription Try For FreeTry Free
$40.15
+0 (+0%)
At Close: Jul 07, 2023
Forecast Insider Trading Signals Historical Prices Predictions Profile
Currently predicting for Mon, 6 May 2024

NVCN.TO Predictions History

3 years ago
 JS predicted that NVCN.TO for 2021-02-16 is going $2.71 (2.26%)

3 years ago
 RAIDERS 67 predicted that NVCN.TO for 2021-02-16 is going

Rank:

3 years ago
 JS predicted that NVCN.TO for 2021-02-10 is going $2.67 (5.53%)

3 years ago
 Rabbie Sameer Hawa predicted that NVCN.TO for 2021-02-10 is going

Rank:
Click to get the best stock tips daily for free!

About Neovasc Inc.

Neovasc. Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incor... NVCN.TO Profile

Golden Star

Ticker Date Change Price
CVBF May 01 2.75% $16.75
FTSL May 01 0.282% $46.03
EQC Apr 30 0.694% $18.72
HRB Apr 30 0.635% $47.23
BSCQ Apr 30 0.576% $19.09
BSJP Apr 29 0.306% $22.91
LYG Apr 29 1.56% $2.56
ORA Apr 29 4.68% $64.48
DHT Apr 24 3.10% $11.28
LPLA Apr 19 3.12% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT